JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

JNJ

186.41

-0.19%↓

ABT

124.42

-1.71%↓

TMO

558.41

+0.1%↑

ISRG

537.45

-1.46%↓

DHR

213.99

-1.31%↓

Search

Co-Diagnostics Inc

Slēgts

SektorsVeselības aprūpe

0.49 -12.5

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.45

Max

0.56

Galvenie mērījumi

By Trading Economics

Ienākumi

-197K

-7.7M

Pārdošana

113K

163K

Peļņas marža

-4,745.023

Darbinieki

132

EBITDA

-526K

-7.8M

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 6. nov.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

52M

61M

Iepriekšējā atvēršanas cena

12.99

Iepriekšējā slēgšanas cena

0.49

Ziņu noskaņojums

By Acuity

90%

10%

356 / 373 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bearish Evidence

Co-Diagnostics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 29. okt. 23:28 UTC

Karstas akcijas

Stocks to Watch: Chipotle, Align, Sprouts Farmers Market, Meta

2025. g. 29. okt. 23:07 UTC

Peļņas

Prudential PLC 3Q New Business Profit Up 13%

2025. g. 30. okt. 00:00 UTC

Peļņas

The Hamptons Luxury Housing Market Is Staging a Comeback for the Ages -- WSJ

2025. g. 30. okt. 00:00 UTC

Peļņas

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

2025. g. 30. okt. 00:00 UTC

Peļņas

Renesas Electronics 9-Mos Loss Y69.09B Vs Net Y197.30B

2025. g. 29. okt. 23:46 UTC

Tirgus saruna

Nikkei May Decline Amid Caution Ahead of BOJ Decision -- Market Talk

2025. g. 29. okt. 23:40 UTC

Peļņas

Meta Shares Fall on Accelerating AI Spending Despite Record Revenue -- WSJ

2025. g. 29. okt. 23:38 UTC

Tirgus saruna

Gold Rises on Possible Dip-Buying After Falling on Powell's Remarks -- Market Talk

2025. g. 29. okt. 23:25 UTC

Peļņas

Alphabet Stock Jumps on Big Earnings Beat -- Barrons.com

2025. g. 29. okt. 22:51 UTC

Peļņas

Google Revenue Soars as AI Boom Lifts Cloud Business -- 2nd Update

2025. g. 29. okt. 22:45 UTC

Peļņas

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 6th Update

2025. g. 29. okt. 22:41 UTC

Peļņas

Prudential PLC 3Q New Business Profit Up 13% on Year to $705.0M >2378.HK

2025. g. 29. okt. 22:41 UTC

Peļņas

Prudential PLC APE Sales Up 10% on Year, to $1.72B >2378.HK

2025. g. 29. okt. 22:09 UTC

Peļņas

Microsoft Reports Strong Earning as Azure Cloud Revenue Soars by 40%. The Stock Is Still Down. -- Barrons.com

2025. g. 29. okt. 22:08 UTC

Tirgus saruna
Peļņas

Starbucks Revamps Stores in Pursuit of 'Warm' Atmosphere -- Market Talk

2025. g. 29. okt. 21:58 UTC

Peļņas

Alphabet Continues to Allocate More Resources to Waymo, CFO Says

2025. g. 29. okt. 21:58 UTC

Peļņas

Alphabet's Google Cloud Backlog Rose on Strong Demand for Enterprise AI, CFO Says

2025. g. 29. okt. 21:57 UTC

Peļņas

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 5th Update

2025. g. 29. okt. 21:54 UTC

Peļņas

Meta's Margins Are Slipping As AI Costs Mount. The Stock Is Falling. -- Barrons.com

2025. g. 29. okt. 21:46 UTC

Peļņas

Alphabet CEO Sees Strong Growth and Momentum for Waymo Continuing in 2026

2025. g. 29. okt. 21:43 UTC

Peļņas

Alphabet's Google Cloud Signing Larger Deals, Deepening Relationships With Existing Customers, CEO Says

2025. g. 29. okt. 21:43 UTC

Peļņas

Alphabet CEO: More Than 70% of Existing Google Cloud Customers Use AI Products

2025. g. 29. okt. 21:42 UTC

Peļņas

IGO 1Q Nova Cash Cost A$6.84/Pound, Up 72% On-Quarter

2025. g. 29. okt. 21:42 UTC

Peļņas

IGO 1Q Nova Copper Output 1,377 Tons, Down 41% On-Quarter

2025. g. 29. okt. 21:41 UTC

Peļņas

IGO 1Q Nova Nickel Sales 3,320 Tons, Down 5% On-Quarter

2025. g. 29. okt. 21:41 UTC

Peļņas

Microsoft's Cloud Services Power Earnings Beyond Wall Street Expectations -- 4th Update

2025. g. 29. okt. 21:41 UTC

Peļņas

Alphabet Signed New Google Cloud Customers Faster in 3Q, CEO Says

2025. g. 29. okt. 21:41 UTC

Peļņas

IGO 1Q Nova Nickel Production 3,429 Tons, Down 33% On-Quarter

2025. g. 29. okt. 21:40 UTC

Peļņas

IGO: Talks Ongoing With Kwinana JV Partner to Settle on Optimum Pathway For Refinery

2025. g. 29. okt. 21:39 UTC

Peļņas

IGO 1Q Kwinana Sustaining, Improvement Capex A$8.3 Million

Salīdzinājums

Cenas izmaiņa

Co-Diagnostics Inc Prognoze

Vērtējuma vienprātība

By TipRanks

Neitrāls

1 ratings

0

Pirkt

1

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

0.3495 / 0.3699Atbalsts un pretestība

Īstermiņā

Bearish Evidence

Vidējā termiņā

Weak Bearish Evidence

Ilgtermiņā

No Evidence

Noskaņojums

By Acuity

356 / 373 Rangs Veselības aprūpe

Ziņu noskaņojums

Ļoti spēcīga liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Co-Diagnostics Inc

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
help-icon Live chat